iSpecimen Inc. (NASDAQ:ISPC) Q4 2022 Earnings Call Transcript March 14, 2023 8:30 AM ET Company Participants Allison Soss - Investor Relations-KCSA Strategic Communications Tracy Curley - Chief Executive Officer Benjamin Bielak - Chief Information Officer Eric Langlois - Chief Revenue Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Allen Klee - Maxim Group Operator Good day, everyone and welcome to iSpecimen's Full Year 2022 Conference Call. At this time, participants will be i ...

iSpecimen Inc. (NASDAQ:ISPC) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Allison Soss - IR Tracy Curley - Interim-CEO and CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Operator Good day, everyone, and welcome to the iSpecimen Third Quarter 2022 Conference Call. [Operator Instructions] This conference call is being recorded. A replay of today's call will be available on the Investor Relations section of iSpecimen's website and will remain posted the ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission File No. 001-40501 iSpecimen Inc. (Exact name of Registrant as specified in its Charter) (State or other jurisdiction ...

iSpecimen Inc. (NASDAQ:ISPC) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Allison Soss - Senior Vice President of Investor Relations Christopher Ianelli - President & Chief Executive Officer Jill Mullan - Chief Operating Officer Tracy Curley - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Constantine Davides - EF Hutton James Lieberman - Revere Securities Operator Good day, everyone and welcome to iSpecimen Second Quarter 202 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission File No. 001-40501 iSpecimen Inc. (Exact name of Registrant as specified in its Charter) (State or other jurisdiction of i ...

| --- | --- | --- | --- | |-----------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | CONNECT. INNOVATE. | | | | | | | | | | | | | | | TRANSFORMING BIOSPECIMEN | | | | | PROCUREMENT An online marketplace for human biospecimens | | | | | May 2022 Investor Presentation | | | | Forward-Looking Statements This presentation may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Sec ...

iSpecimen Inc. (NASDAQ:ISPC) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Allison Soss - Investor Relations Christopher Ianelli - Chief Executive Officer and President Tracy Curley - Chief Financial Officer Jill Mullan - Chief Operating Officer Conference Call Participants Matthew Hewitt - Craig-Hallum Capital Group Constantine Davides - EF Hutton Operator Good day, everyone, and welcome to iSpecimen's First Quarter 2022 Conference Call. [Operator Instructions] This confere ...

Table of Contents For the Quarterly Period Ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission File No. 001-40501 iSpecimen Inc. (Exact name of Registrant as specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 27-0480143 (I.R.S. Empl ...

For The Transition Period From To Commission file number: 001-40501 iSpecimen Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact name of registrant as specified in its charter) Delaware 27-0480143 (State of other jurisdiction of incorporation o ...

Call Start: 08:30 January 1, 0000 8:53 AM ET iSpecimen Inc. (NASDAQ:ISPC) Q4 2021 Earnings Conference Call February 17, 2022, 8:30 ET Company Participants Christopher Ianelli – Chief Executive Officer and President Tracy Curley – Chief Financial Officer Jill Mullan – Chief Operating Officer Allison Soss – Investor Relations Conference Call Participants Lucas Baranowski – Craig-Hallum Operator Good day, everyone and welcome to iSpecimen's Full-Year 2021 Conference Call. At this time, all participants are in ...